YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 91, Issue 2, 2011, Pages

  Yasuda, Tetsuyuki ^a   Kaneto, Hideaki ^a   Katakami, Naoto ^a   Kuroda, Akio ^a   Matsuoka, Taka aki ^a   Yamasaki, Yoshimitsu ^a   Matsuhisa, Munehide ^b   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Albuminuria; Type 2 diabetes; YKL 40

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CHITINASE 3 LIKE 1 PROTEIN; HEPARIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ALBUMINURIA; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD SAMPLING; CAROTID ARTERY; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE;

ADIPOKINES; AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCOPROTEINS; HUMANS; LECTINS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 79952037641     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.11.015     Document Type: Article

References (15)

1. Hakala B.E., White C., Recklies A.D. Human cartilage gp-39, a major secretory product protein family. J Biol Chem 1993, 268:25803-25810.
2. Rehli M., Krause S.W., Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stages of macrophage differentiation. Genomics 1997, 43:221-225.
3. Malinda K.M., Ponce L., Kleinman H.K., Shackelton L.M., Millis A.J. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999, 250:168-173.
4. Rathcke C.N., Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006, 55:221-227.
5. Dinneen S.F., Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: a systemic overview of the literature. Arch Intern Med 1997, 157:1413-1418.
6. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421-426.
7. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia 1989, 32:219-226.
8. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
9. Katakami N., Matsuhisa M., Kaneto H., Matsuoka T.A., Sakamoto K., Nakatani Y., et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. Diabetes Care 2005, 28:2716-2721.
10. Schalkwijk C.G., Stehouwer C.D. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005, 109:143-159.
11. Volck B., Price P.A., Johansen J.S., Sørensen O., Benfield T.L., Nielsen H.J., et al. YKL-40, a mammalian member of the chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Physicians 1998, 110:351-360.
12. Nishikawa K.C., Millis A.J. Gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells. Exp Cell Res 2003, 287:79-87.
13. Kucur M., Isman F.K., Karadag B., Vural V.A., Tavsanoglu S. Serum YKL-40 levels in patients with coronary artery disease. Coron Artery Dis 2007, 18:391-396.
14. Wang Y., Ripa R.S., Johansen J.S., Gabrielsen A., Steinbruchel D.A., Friis T., et al. YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary disease. Scand Cardiovasc J 2008, 42:295-302.
15. Kastrup J., Johansen J.S., Winkel P., Hansen J.F., Hildebrandt P., Jensen G.B., et al. High serum YKL-40 concentration is associated with cardiovascular artery disease. Eur Heart J 2009, 30:1066-1072.